Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 5/20 | 0.54 |
| ▸ | HTR2A | P28223 | 4/20 | 0.54 |
| ▸ | HTR2B | P41595 | 3/20 | 0.54 |
| ▸ | HTR3A | P46098 | 3/20 | 0.53 |
| ▸ | HTR1A | P08908 | 2/20 | 0.53 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.53 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.53 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.53 |
| ▸ | FPR3 | P25089 | 1/20 | 0.53 |
| ▸ | HTR1D | P28221 | 1/20 | 0.53 |
| ▸ | HTR1B | P28222 | 1/20 | 0.53 |
| ▸ | HTR1E | P28566 | 1/20 | 0.53 |
| ▸ | GPR183 | P32249 | 1/20 | 0.53 |
| ▸ | HTR7 | P34969 | 1/20 | 0.53 |
| ▸ | HRH1 | P35367 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.53 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24918718 | 1.00 | HTR2C (0.54) | HTR2CHTR2AHTR2BHTR3AHTR1A | |
| SCHEMBL29664028 | 0.84 | HTR2C (0.44) | HTR2CHTR2AHTR2BHTR3AHTR1A | |
| SCHEMBL23363259 | 0.84 | HTR2C (0.44) | HTR2CHTR2AHTR2BHTR3AHTR1A | |
| Hydrochloric Acid SCHEMBL31479953 | 0.83 | HTR2C (0.45) | HTR2CHTR2AHTR2BHTR3AHTR1A | |
| SCHEMBL30138390 | 0.81 | PLD1 (0.56) | HTR2CHTR2AHTR2BHTR3AHTR1A | |
| SCHEMBL23384872 | 0.81 | PLD1 (0.56) | HTR2CHTR2AHTR2BHTR3AHTR1A | |
| SCHEMBL23385197 | 0.80 | HTR2C (0.53) | HTR2CHTR2AHTR2BHTR3AHTR1A | |
| SCHEMBL24147522 | 0.78 | HTR2A (0.53) | HTR2CHTR2AHTR2BHTR3AHTR1A | |
| SCHEMBL29668697 | 0.78 | HTR2A (0.53) | HTR2CHTR2AHTR2BHTR3AHTR1A | |
| Hydrochloric Acid SCHEMBL25385019 | 0.77 | HTR3A (0.54) | HTR2CHTR2AHTR2BHTR3AHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11932618-B2 | GLP-1 receptor agonist and use thereof | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2024-03-19 | — | — | US | disclosed |
| US-20230212140-A1 | GLP-1 RECEPTOR AGONIST AND USE THEREOF | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-11643403-B2 | GLP-1 receptor agonist and use thereof | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-05-09 | — | — | US | disclosed |
| US-20230013143-A1 | GLP-1 RECEPTOR AGONIST AND USE THEREOF | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230013143-A1 | GLP-1 RECEPTOR AGONIST AND USE THEREOF | GLP1R, GIPR, GPR119 | HTR2C 493/4885HTR2A 459/4885HTR2B 407/4885 |
| US-20230212140-A1 | GLP-1 RECEPTOR AGONIST AND USE THEREOF | GLP1R, GIPR, GPR119 | HTR2C 493/4885HTR2A 459/4885HTR2B 407/4885 |
| US-11643403-B2 | GLP-1 receptor agonist and use thereof | GLP1R, GIPR, GPR119 | HTR2C 493/4885HTR2A 459/4885HTR2B 407/4885 |
| US-11932618-B2 | GLP-1 receptor agonist and use thereof | GLP1R, GIPR, GPR119 | HTR2C 493/4885HTR2A 459/4885HTR2B 407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.